Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CES2 | O00748 | 2/20 | 0.47 |
| ▸ | MEN1 | O00255 | 1/20 | 0.46 |
| ▸ | THRB | P10828 | 1/20 | 0.46 |
| ▸ | HTT | P42858 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | NAAA | Q02083 | 1/20 | 0.41 |
| ▸ | DGKA | P23743 | 1/20 | 0.41 |
| ▸ | HCAR2 | Q8TDS4 | 1/20 | 0.39 |
| ▸ | EPHX1 | P07099 | 1/20 | 0.39 |
| ▸ | PLA2G2C | Q5R387 | 2/20 | 0.38 |
| ▸ | TSHR | P16473 | 2/20 | 0.38 |
| ▸ | PAM | P19021 | 2/20 | 0.38 |
| ▸ | USP2 | O75604 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6515494 | 1.00 | CES2 (0.47) | CES2MEN1THRBHTTKMT2A | |
| SCHEMBL6524363 | 0.93 | TSHR (0.39) | CES2MEN1THRBHTTKMT2A | |
| SCHEMBL6524369 | 0.93 | TSHR (0.39) | CES2MEN1THRBHTTKMT2A | |
| SCHEMBL6518164 | 0.90 | NAAA (0.50) | CES2NAAAHCAR2EPHX1TSHR | |
| SCHEMBL6531444 | 0.90 | NAAA (0.50) | CES2NAAAHCAR2EPHX1TSHR | |
| SCHEMBL6531441 | 0.90 | NAAA (0.50) | CES2NAAAHCAR2EPHX1TSHR | |
| SCHEMBL6518156 | 0.90 | NAAA (0.50) | CES2NAAAHCAR2EPHX1TSHR | |
| SCHEMBL6513694 | 0.86 | HSD17B10 (0.36) | MEN1THRBKMT2AHCAR2TSHR | |
| SCHEMBL6513684 | 0.86 | HSD17B10 (0.36) | MEN1THRBKMT2AHCAR2TSHR | |
| SCHEMBL6520964 | 0.83 | ALDH1A1 (0.48) | HTTMAPTNAAAHCAR2EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-6958366-B2 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2005-10-25 | — | — | US | disclosed |
| US-20030118544-A1 | Antifouling coating composition and novel resin | DAINIPPON INK AND CHEMICALS, INC. (JP) | 2003-06-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20030118544-A1 | Antifouling coating composition and novel resin | COL1A1, GLRA1, COL2A1 | CES2 450/4885MEN1 3248/4885THRB 3136/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.